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T92-0045: Interlaboratory quality control on Tpot measurements. 
P.A. Coucke on behalf of the members of NC1 T92-0045 collaborative group (*). 
Study chair and data management, Centre Hospitalier Universitaire Vaudois, Dpt of Radiation-Oncology, Lausanne - Switzerland. 
(*) Multicentric international collaboration: K. Beer (CH), J. Bemier (CH), V. Budach (Ger), C. Foy (UK), J-P. Gerard (F), J-C. Horiot, M. 
Kinay (Tr), P. Lagarde (F), P. Maingon (F), P. Mere(F), Ph. Martin (F), B. Mermillod (CH), R. Miralbell (CH), R-O. Mirimanoff (CH), A. 
Momrier (F), F. Momex (F), T.D. Nguyen (F), N. Paschoud (CH), J-J. Pavy (F), B. Prevost (F), G. Ries (CH), W. Rogowski (PI), G. Storme 
(B), K. Weber-Johnson (CH), P. Weber (CH), G.D. Wilson (UK), A. Zouhair (CH). 
Purpose/objective: 
To assess the reproducibility of Tpot measurement by comparison between three laboratories. 
Materials and methods: 
We will report on the intercomparison which contains two arms: a single set of data (disc analysis), stained, processed and analysed in Lab1 
has subsequently been analyzed by the team in the Lab 2 and in Lab 3. This kind of comparison reveals differences in interpretation and region 
setting. Pieces of the original tumor specimen have been processed, stained and analyzed separately in each centre (meat analysis). This latter 
reveals variation in dissociation, staining and running the sample, but also illustrates tumor heterogeneity. All three laboratories are equipped 
with a Becton Dickinson FACScan and are using PC-Lysis for analysis. The procedure for handling the sample has been standardized before 
starting the comparison; guidelines were elaborated for setting the gates. The mathematical algorithm modified from A. Begg has been used. 
The study consists of 102 specimens from 97 patients with following breakdown: 25 gynecological, 36 head and neck, 35 rectal and 6 
pulmonary cancers. In order to compare Tpotdata the method of Bland and Altman has been used which yields limits of agreement. This 
method gives a better impression on the true correlation between centers as compared to the correlation coefficients. Moreover, it results in a 
closer estimate of the variation on an individual specimen. The analysis has been done on the 102 specimens but a second analysis has been 
performed on 89 biopsies, after having excluded outliers, with obvious aberrant values. 
Results: 
The Bland and Altman analysis of log Tpot for all 102 samples yields small mean differences (range of logdata 0.004 to 0.151), but large 
standard deviations (range 0.286 to 0.407 in logdata). Converting the logdata to days yields a mean difference of 1 - day and a standard 
deviation ranging from 1.9 to 2.6 days. Restricting the analysis to 89 samples (excluding obvious aberrant outliers), improves the standard 
deviation to a range of 0.161 - 0.326. This results in a standard deviation of 1.45 - 2.1 days. This improvement is only observed for disc data 
and not for meuf data. 
Conclusions: 
Comparison of on disc yields good agreement after removal of a few obviously aberrant results. The lack of improvement for meat data after 
having removed aberant results might reflect tumor heterogeneity. 
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AN ANTI-ANGIOGENIC AGENT (TNP-470) INHIBITED REOXYGENAT’ION DURING FRACI-IONATED RADIOTHEXAPY OF MURINE 
MAMMARY CARCINOMA 
Murata Rumi, Nishimura Yasumasa, and Him&a Masahim 
Depamnent of Radiology, Faculty of Medicine, Kyoto University, Kyoto, 606-01, Japan. 
Purpose: Angiogenesis is one of the important factors for tumor growth. Therefore. an angingenesis inhibitor might decelerate tumor npopulation and 
is expected to impmve the tumor cnnnul rate in fractionated radiotherapy (RT). On the other hand, it might incmase hypoxic fraction of tumors or inhibit 
tumor tenxygenation during fractionated RT. This study investigated the effects of an angiogenesis inhibitor on fmctionated RT. 
Materials and Methods: Animal-tumors wem early generation isotransplants of mammary carcinoma in C3H/He mice. Tumor response was studied 
by tumor growth (TG) time and TCDJO (50% tumor control dose) assays. Treatments were started when tumors on the right paw grew 4-5 mm in 
diameter Radiation was locally given to tumors in ah or under hypoxic condition. An angiogenesis inhibitor, TNP-470, a synthetic analogue of 
tunragillin which is a natural pmduct of Aspergillus jlunigotus, has been teported to inhibit endothelial cell growth in vitro. RIP-470 was administered 
S.C. twice a week at a dose of lOChng/kg. In the TG time assay, fmcticnated RT was delivered daily for 5 days to a total dose of 1OGy (2GyEraction x 5). 
Two or four doses of TNP-470 were administered during and/or after fractionated RT. The time required for a tumor to reach 3-fold of initial tumor 
volume (TG time) was detemtined for each group. In the TCD-50 assay, a single or fractionated irmdiation was given alone or in combination with TNP- 
470. Fraction& itradiation was &slivered daily, five times per week, over two weeks (10 fractions). Chte dose of TNP-470 was administered 24 h prior 
to a single dose of irradiation, whereas four doses of TNP-470 were given during fractionated RT. Tumors were observed for recunence once a week 
for 120 days following the end of RT. 
Results: The TG time for no neatment group, a group treated with fractionated RT alone, or two doses of TNP-470 alone was 5.3 days (95% 
contidence limits: 4.8-5.9), 15.6 days (15.1-16.1) or 7.8 days (7.1-8.5). respectively. Signifiiant &lay of tumor growth was observed by TNP-470 
alone (lOOmg/kg x 2), indicating that TNP-470 alone has antitumor effect in vivo (p < 0.001). This antitumor effect of TNP-470 was not obsetved when 
this drug was given during fractionated RT. However, TNP-470 given after the end of fractionated RT showed significantly additional growth delay. The 
values of TCD-50 am as follows; 
TNP-470 given prior to RT did not ala hypoxic fraction of 
Q hunors significantly. TNP-470 administered during 
m inair 53.1 (49.9 -56.5) 49.4 (46.5 - 52.5) NS 6actilnmtedKT&reasedradiocurabiityofthetumors inair, 
hypoxic 56.8 (56.3 - 57.3) 54.7 (52.4 - 57.1) NS although no diffemnce in TCD543 was observed under hypoxic 
Jo’ ‘. inair 77.3 (73.5 -81.3) 67.4 (65.2 - 69.7) p < 0.005 caldidon. It suggested that TNP-470 inhibited renxygenation 
124.5 (l&7 - 130.71 121.1) NS during 1CMraction RT. 
Conclusions: TNP-470 &owed alditional tumor growth delay in the TG time assay, only when it was given i4fm the whole course of fractionattd RT. 
In the TCD-50 assay, administration of TNP-470 during 10 fractions of RT de4mawd the local tumor control rate. These results suggest that 
reoxygenation during ftwhmed RT might be inhibited by TNP-470. when W-470 is combined with m RT, administmdon after the end of 
RT is -mended. 
